CEBEMIRA-S 25/5 TABLETS

Product Details :

Feature	Details
Product Name	CEBEMIRA-S 25/5 Tablets
Form	Tablets
Key Ingredients	Telmisartan 25 mg + Cilnidipine 5 mg
Core Benefits	Controls blood pressure, protects heart and kidneys
Mechanism of Action	ARB + Calcium Channel Blocker: relaxes blood vessels, reduces resistance
Support Areas	Hypertension, cardiovascular protection, renal safety
Recommended Usage	1 tablet once daily or as prescribed by a physician
Target Audience	Adults with mild-to-moderate hypertension

Composition: Mirabegron 25mg Extended Release + Solifenacin 5mg Packing: 10×10 Alu-Alu

Description : CEBEMIRA-S 25/5 Tablets combine Cilnidipine 5 mg and Telmisartan 25 mg, offering a dual-action treatment for hypertension (high blood pressure). Telmisartan, an angiotensin II receptor blocker (ARB), lowers blood pressure by relaxing blood vessels, while Cilnidipine, a calcium channel blocker, also controls BP and protects against cardiovascular damage. This combination helps reduce the risk of heart attacks, strokes, and kidney complications in hypertensive patients. CEBEMIRA-S 25/5 ensures effective and sustained blood pressure control with once-daily dosing under medical supervision.